Zahra Eslami-S received her bachelor’s degree in molecular and cellular biology and a master’s degree in Genetics. After working in different research institutes, she received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant and joined LCCRH in 2018 to pursue Ph.D concentrating on different aspects of liquid biopsy. During her Ph.D she has the opportunity to expand her expertise about different liquid biopsy biomarkers like CTCs, ctDNA, EVs, and platelets.She obtained her PhD in 2022 and continues to work with Dr. Alix-Panabieres as a post-doctoral researcher. She is involved in different clinical trial studies which are running in the LCCRH. Moreover, she is responsible for the project to develop new technology for CTC functional study.